| 杜秀生,武少鹏,孙达亮.三碘甲状腺原氨酸对双相抑郁增效治疗的研究进展[J].四川精神卫生杂志,2019,32(1):91-93.,Review of triiodothyronine in the treatment of bipolar depression[J].SICHUAN MENTAL HEALTH,2019,32(1):91-93 |
| 三碘甲状腺原氨酸对双相抑郁增效治疗的研究进展 |
| Review of triiodothyronine in the treatment of bipolar depression |
| |
| DOI：10.11886/j.issn.1007-3256.2019.01.021 |
| 中文关键词: 甲状腺激素 双相障碍 双相抑郁 疗效 |
| 英文关键词:Thyroid hormones Bipolar disorder Bipolar depression Efficacy |
| 基金项目:天津市卫生计生委2015年重点项目(2015KR01) |
|
| 摘要点击次数: |
| 全文下载次数: |
| 中文摘要: |
| 【摘要】 甲状腺激素异常与心境障碍发病密切相关。 尽管目前双相抑郁诊断识别率有所提高，但其治疗现状并不乐观。加拿大心境及焦虑治疗指导组(CANMAT)建议将三碘甲状腺原氨酸( T3 ) 作为双相 II 型抑郁急性期管理的三线联合治疗药物。本文就 T3 对双相抑郁增效治疗有效性的相关文献做一综述，以期为双相抑郁治疗的临床实践提供参考。 |
| 英文摘要: |
| Abnormal level of the thyroid hormones was closely related to the pathogenesis of mood disorder. The recognition rate of bipolar disorder had been improved, while the efficacy of treatment was not good. As Canadian Network for Mood and Anxiety Treatments( CANMAT) suggested T3 as the third line approach for bipolar Ⅱ depression during the acute phrase. This article reviewed the literature on the effectiveness of T3 in the treatment of bipolar depression, in order to provide references for the clinical practice of the treatment on bipolar depression. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |